NCT07069101 Continuous Erector Spinae Block Versus Continuous Edge of Laminar Block on The Quality of Analgesia and Diaphragmatic Excursion in Patients With Multiple Rib Fractures
| NCT ID | NCT07069101 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Erector Spinae Block |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2024-11-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective randomized clinical trial aims to compare the effect of continuous erector spinae plane block versus continuous edge of laminar block on the quality of analgesia and diaphragmatic excursion in patients with unilateral traumatic multiple rib fractures.
Eligibility Criteria
Inclusion Criteria: * Aged between 21 and 65 years. * Both sexes. * With unilateral traumatic multiple fracture ribs (≥ 3), admitted to the surgical intensive care unit within the first day of trauma. Exclusion Criteria: * Patients' rejection. * Body mass index ≥ 35 (kg/m2). * Bleeding and Coagulation disorders. * Known hypersensitivity to the study drugs. * Vertebral deformity. * Respiratory, cardiac, renal or hepatic dysfunction. * Patients with major trauma involving extra-thoracic structures (e.g., head, spine, pelvis, and abdominal visceral injuries). * Mental or cognitive dysfunction, * History of chronic analgesic or drug abuse. * Local infection at the site of the block.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07069101 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 65 Years, studying Erector Spinae Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07069101 currently recruiting?
Yes, NCT07069101 is actively recruiting participants. Contact the research team at heba.abdelhamid@med.tanta.edu.eg for enrollment information.
Where is the NCT07069101 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT07069101 clinical trial?
NCT07069101 is sponsored by Tanta University. The trial plans to enroll 70 participants.